ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Start-ups

Life sciences investment firm Westlake launches

by Lisa M. Jarvis
September 9, 2018 | APPEARED IN VOLUME 96, ISSUE 36

 

A new life sciences venture fund, Westlake Village BioPartners, has launched with $320 million to spend on early-stage companies. Westlake was founded by Beth Seidenberg, formerly a partner at the venture capital firm Kleiner Perkins, and Sean Harper, Amgen’s former head of R&D, who will join Westlake in January. Seidenberg brings 12 years of experience incubating biotech firms—many of which went public or were acquired—along with years working at big firms like Amgen, Bristol-Myers Squibb, and Merck & Co.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment